MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
GoodRx Holdings Retained Earnings 2011-2026 | GDRX
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings GoodRx Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.44 B | -1.46 B | -1.45 B | -1.42 B | -1.39 B | -1.1 B | -1.16 B | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.1 B | -1.46 B | -1.34 B |
Quarterly Retained Earnings GoodRx Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.42 B | -1.42 B | -1.43 B | -1.45 B | -1.45 B | - | -1.43 B | -1.39 B | -1.45 B | -1.45 B | - | -1.4 B | -1.4 B | -1.42 B | -1.38 B | -1.36 B | -1.39 B | -1.39 B | -1.39 B | -1.39 B | -1.39 B | -1.1 B | -1.1 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -1.1 B | -1.45 B | -1.38 B |
Retained Earnings of other stocks in the Health information services industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
-372 M | - | 0.29 % | $ 206 M |  USA |
 |
Change Healthcare
CHNG
|
-1.1 B | - | - | $ 9.03 B | USA |
 |
Cerner Corporation
CERN
|
6.75 B | - | - | $ 27.9 B | USA |
 |
American Well Corporation
AMWL
|
-2.06 B | $ 5.63 | -2.26 % | $ 90.3 M | USA |
 |
Computer Programs and Systems
CPSI
|
8.13 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
-1.08 B | - | - | $ 2.94 B | USA |
 |
Castlight Health, Inc.
CSLT
|
-517 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
580 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
301 M | - | - | $ 6.37 B | USA |
 |
HealthStream
HSTM
|
109 M | $ 21.23 | 1.24 % | $ 645 M | USA |
 |
iCAD
ICAD
|
-277 M | - | - | $ 102 M | USA |
 |
Evolent Health
EVH
|
-606 M | $ 2.27 | 0.89 % | $ 213 M | USA |
 |
NextGen Healthcare
NXGN
|
129 M | - | - | $ 1.6 B | USA |
 |
Omnicell
OMCL
|
383 M | $ 34.94 | 1.39 % | $ 1.61 B | USA |
 |
1Life Healthcare
ONEM
|
-618 M | - | - | $ 3.37 B | USA |
 |
OptimizeRx Corporation
OPRX
|
-64.3 M | $ 7.18 | 5.9 % | $ 123 M | USA |
 |
MTBC
MTBC
|
-55.8 M | - | -0.58 % | $ 51.7 M | USA |
 |
Phreesia
PHR
|
-743 M | $ 11.28 | - | $ 615 M | USA |
 |
Premier
PINC
|
-485 M | - | - | $ 2.33 B | USA |
 |
Schrödinger
SDGR
|
-629 M | $ 11.4 | -1.47 % | $ 837 M | USA |
 |
Signify Health
SGFY
|
-558 M | - | -0.02 % | $ 7.21 B | USA |
 |
R1 RCM
RCM
|
-64.3 M | - | - | $ 3.81 B | USA |
 |
Akerna Corp.
KERN
|
-67.7 M | - | - | $ 161 M | USA |
 |
Zhongchao
ZCMD
|
-7.96 M | $ 1.8 | -0.55 % | $ 9.37 M |  China |
 |
Streamline Health Solutions
STRM
|
-126 M | - | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
-16.4 B | $ 5.57 | 2.77 % | $ 982 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
768 M | - | -10.39 % | $ 886 M | USA |
 |
10x Genomics
TXG
|
-1.28 B | $ 20.91 | 5.55 % | $ 2.45 B | USA |
 |
Health Catalyst
HCAT
|
-1.36 B | $ 1.1 | 0.46 % | $ 76.9 M | USA |
 |
NantHealth
NH
|
-1.12 B | - | -46.64 % | $ 10.4 M | USA |
 |
HealthEquity
HQY
|
196 M | $ 82.47 | 0.45 % | $ 7.1 B | USA |
 |
SCWorx Corp.
WORX
|
-31 M | $ 0.13 | 1.5 % | $ 190 K | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-408 M | - | - | $ 255 M | USA |
 |
Progyny
PGNY
|
144 M | $ 17.75 | -1.66 % | $ 1.52 B | USA |
 |
So-Young International
SY
|
-926 M | $ 3.19 | 9.62 % | $ 253 M | China |
 |
Veeva Systems
VEEV
|
4.36 B | $ 178.11 | -0.56 % | $ 29.2 B | USA |